Mortality of obese patients affected by covid-19 in the state of paraíba: a descriptive analysis
DOI:
https://doi.org/10.36489/saudecoletiva.2021v11i69p8415-8426Keywords:
Mortality, Obesity, Coronavirus lnfectionsAbstract
Objective: To describe and quantify the data provided by the government of the state of Paraíba in relation to the mortality of obese patients affected by COVID-19 in the state. Method: A descriptive and quantitative study was carried out based on epidemiological information on the mortality of obese patients affected with COVID-19 in the state of Paraíba, using the variables: date of death, sex, age, method of diagnosis, onset of symptoms, municipality of residence and pre-existing illness. Results: Most deaths are concentrated in the year 2021, in notoriety in March with 149 deaths, predominantly female, the most affected ages were 61 and 68 years, confirmation of infection mostly by Swab test, 155 patients started symptoms in March/2021, 102 municipalities in Paraíba. were identified, in addition to obesity and preexisting diseases were found. Conclusion: The study demonstrated obesity as a relevant factor in mortality from COVID-19 in Paraíba.
References
Junio do Nascimento F, Ferreira Silva DR, Cavalcanti Barbosa, HCB, Ferreira dos Santos V, Mascarenhas Martins L, Rodrigues Pereira Luz DC. Sobrepeso e obesidade em adolescentes escolares: uma revisão sistemática. Saúde Coletiva. 2020; 10(55): 2947-2958. Disponível em: https:ffdoi.org/10.36489/saudecoletiva.2020v1Oi55p2947-2958 2. Valeria A, Nisoli E, Rossi AP, Pellegrini M, Todesco T, EI Ghoch M. Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet. J PopulTher Clin Pharmacol. 2020; 27(5 Pt 1): 31-36. Disponível em: https:ffpubmed. ncbi.nlm.nih.gov/32650354/. 3. Ryan OH, Ravussin E, Heymsfield S. COVID 19 and the Patient with Obesity -The Editors Speak Out. Obesity. 2020; 28(5): 84 7-847, Disponível em: https:ffonlinelibrary.wiley.com/doi/ full/10.1002/oby.22808. 4. Busetto 1, Bettini S, Fabris R, Serra R. Maffei P, Rossato M, Floretto P, Vettor R. Obesity and COVID-19: An ltalian Snapshot. The Obesity Society. 2020; 28(9): 1600-1605. Disponível em: https:§ onlinelibrary.wiley.com/doi/10.1002/oby.22918. 5. Rychter AM, Zawada A, Ratajczak AE, Dobrowolska A, KrelaKazmierczak 1. Should patients with obesity be more afraid of COVID-19? Obes Rev. 2020: 21(9): e13083. Disponível em: https:ff pubmed.ncbi. n I m .ni h.gov /3258353 7 /. 6. Paraíba. Governo do Estado da Paraíba. Painel Coronavírus Paraíba; 2021. Disponível em: https:ffsuperset.plataformatarget. com.br/superset/dashboard/55/. 7. Borges GM, Crespo CD. Demographic and socioeconomic characteristics of Brazilian adults and COVID-19: a risk group analysis based on the Brazilian National Health Survey, 2013. Cadernos de saúde pública. 2020; 36(10): e00141020. Disponível em: https:ff www.scielo.br/j/csp/a/YKRHjz3cSF5sphHX3WVzJRm/?lang=en. 8. Bolsoni-Lopes A, Furieri LB, Alonso-Vale MIC. Obesidade e a covid-19: uma reflexão sobre a relação entre as pandemias. Rev Gaúcha Enferm. 2021;42(spe):e20200216. Disponível em: https:§doi.org/10.1590/1983- 144 7.2021.20200216. 9. Soares AJ, Soares CFS, Santos Silva FC, Ferreira da Silva A, Estrela FM, Magalhães JRF, Oliveira MAS, Lima AM, Elementos da masculinidade que vulnerabilizam homens à morbimortalidade pela COVI D-19: revisão integrativa. Revista Saúde Coletiva. 2021; 11(65): 5926-5932. Disponível em: https:§doi.org/10.36489/ saudecoletiva.2021 v11 i65p5926-5939. 10. Brasil. Ministério da Saúde. COVID - 19 no Brasil. Brasília (DF); 2021. Disponível em: https:ffqsprod.saude.gov.br/extensions/covid-19_html/covid-19 _html.html. 11. Goularte OS, Dias EP, Gonçalves SL, Martin PS, Gabriel As, Chin CM. Manifestações clínicas, fatores de risco e diagnóstico na COVID-19. Revista Unilago. 2020; 1(Esp): 23-30. Disponível em: http:ffrevistas.unilago.edu.br/index.php/ulakes/article/ view/254.
